Announcements Trials

Browse Landscape

Phase

Phase 1 7 Phase 2 6 Phase 3 4 Phase NA 3 Phase 1/2 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 134 Neoplasms 112 Polycystic Ovary Syndrome 66 Prostatic Neoplasms 63 Colorectal Neoplasms 51 Carcinoma, Non-Small-Cell Lung 47 Pain 40 Carcinoma, Hepatocellular 35 Lung Neoplasms 34 Keratosis, Actinic 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Pain, Postoperative 26 Neoplasm Metastasis 26 Head and Neck Neoplasms 26 Stomach Neoplasms 24 Colonic Neoplasms 23 Multiple Myeloma 22 Brain Neoplasms 21 Pancreatic Neoplasms 20 Lymphoma, Follicular 19 Leukemia 19 Anemia 19 Uterine Cervical Neoplasms 18 Leukemia, Myeloid, Acute 18 Infertility 18 Leiomyoma 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Cancer Pain 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Virus Diseases × Clear all

NCT00925288 2012-10-11

Girasol

Johns Hopkins Bloomberg School of Public Health

Phase 4 Completed

200 enrolled 9 charts

Virus Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡